NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

NEW HAVEN, Conn. (WTNH) — Even though multiple sclerosis, also known as MS, is a chronic lifelong disease, there are ways to manage and treat it. Recently, the FDA approved a new drug, Tyruko, ...

Medically reviewed by Brigid Dwyer, MD Key Takeaways Disease-modifying therapies slow down the progression of multiple ...

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

BARCELONA, Spain — In a noninferiority trial in pediatric-onset multiple sclerosis (POMS), ocrelizumab met its primary endpoint compared with fingolimod, demonstrating better tolerability and greater ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Multiple Sclerosis Market and Competitive Landscape Highlights - 2016" report to their offering. The latest ...